| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | HKEX Exchange | Y7742Z103 CUSIP |
| Hong Kong Country | 1,471 Employees | - Last Dividend | - Last Split | - IPO Date |
Shenzhen Neptunus Interlong Bio-technique Company Limited is a dynamic enterprise that focuses on the research, development, production, and sale of medicines and medical devices across the People's Republic of China. With its roots deeply embedded in Quarry Bay, Hong Kong, it operates as a significant subsidiary under the auspices of Shenzhen Neptunus Bio-engineering Company Limited. The company prides itself on its comprehensive portfolio that addresses various therapeutic needs while simultaneously engaging in the commerce and distribution of healthcare food products. Furthermore, it undertakes endeavors in the realm of biological technology research and development, cementing its position as a notable entity in the biomedical sector.
The company’s offerings can be broadly categorized into two main areas: medicinal products and auxiliary services, each tailored to cater to comprehensive healthcare needs. Below is a breakdown of its primary products and services: